Nephrology
Conference Coverage
Children with resistant UTIs unexpectedly may respond to discordant antibiotics
A low rate of care escalation and high rate of clinical improvement suggest this may be a reasonable approach until urine culture sensitivities...
Article
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate...
Conference Coverage
New model for CKD risk draws on clinical, demographic factors
The equation has demonstrated high discrimination and variable calibration across a range of populations.
Conference Coverage
Patiromer allows more CKD patients to continue on spironolactone
PHILADELPHIA – After 12 weeks, 86% of the patiromer patients remained on spironolactone, vs. 66% of the placebo patients.
Renal Consult
Proteinuria and Albuminuria: What’s the Difference?
Proteinuria and albuminuria are not the same thing—but they’re both important. Here’s how to “read” the lab report.
Renal Consult
Acute Kidney Injury: Treatment Depends on the Cause
What exactly is acute kidney injury? Our expert explains how to identify and manage this spectrum of conditions affecting the kidney.
News
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
News
USPSTF: Screening pregnant women for asymptomatic bacteriuria cuts pyelonephritis risk
But the new recommendations urge clinicians to refrain from testing asymptomatic nonpregnant women and adult men.
News
Farxiga gets Fast Track status from FDA
Conference Coverage
Urine albumin testing is crucial for patients at risk for CKD, but drop the 24-hour urine test
SAN DIEGO – An update on diagnosing, managing, and treating patients with comorbid hypertension and diabetes.